Bottom line
How much do IBB and FBTAX overlap?
30% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 39.5% of IBB's assets and 24.9% of FBTAX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings IBB and FBTAX have in common
| Holding | % of IBB | % of FBTAX | Overlap |
|---|---|---|---|
| Vertex Pharmaceuticals, Inc. | 7.66% | 1.39% | 1.39% |
| Gilead Sciences, Inc. | 7.52% | 5.70% | 5.70% |
| Amgen, Inc. | 7.50% | 2.37% | 2.37% |
| Alnylam Pharmaceuticals, Inc. | 5.68% | 3.62% | 3.62% |
| Argenx SE | 3.15% | 3.00% | 3.00% |
| Insmed, Inc. | 2.95% | 3.05% | 2.95% |
| Natera, Inc. | 2.11% | 1.43% | 1.43% |
| Biogen, Inc. | 2.03% | 2.71% | 2.03% |
| Moderna, Inc. | 0.88% | 1.60% | 0.88% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IBB
- BlackRock Funds III — 13.18%
- Regeneron Pharmaceuticals, Inc. — 5.70%
- IQVIA Holdings, Inc. — 3.18%
- Mettler-Toledo International, Inc. — 2.49%
- BeOne Medicines Ltd. — 2.11%
- United Therapeutics Corp. — 1.82%
- Waters Corp. — 1.77%
- Incyte Corp. — 1.62%
- Illumina, Inc. — 1.41%
- Genmab A/S — 1.38%
- Neurocrine Biosciences, Inc. — 1.34%
- Medpace Holdings, Inc. — 1.16%
- Exelixis, Inc. — 1.07%
- Ionis Pharmaceuticals, Inc. — 1.03%
- BioMarin Pharmaceutical, Inc. — 1.02%
Only in FBTAX
- Abbvie Inc — 14.71%
- Spyre Therapeutics Inc — 3.83%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Revolution Medicines Inc — 3.00%
- Ascendis Pharma A/s — 2.99%
- Mbx Biosciences Inc — 2.45%
- Amylyx Pharmaceuticals Inc — 2.25%
- Vaxcyte Inc — 1.97%
- Fidelity Revere Street Trust — 1.96%
- Relay Therapeutics Inc — 1.58%
- Viridian Therapeutics Inc — 1.53%
- Kiniksa Pharmaceuticals International Plc — 1.41%
- Enliven Therapeutics Inc — 1.25%
Asset mix
| Asset type | IBB | FBTAX |
|---|---|---|
| Stocks | 99.8% | 98.2% |
| Cash & short-term funds | 13.4% | 2.4% |
| Preferred stock | — | 1.5% |
| Bonds | — | 0.1% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)
Country mix
| Country | IBB | FBTAX |
|---|---|---|
| US | 98.6% | 87.8% |
| NL | 4.3% | 4.3% |
| DK | 2.2% | 3.0% |
| CH | 2.7% | — |
| KY | 0.9% | 1.8% |
| GB | 1.0% | 1.8% |
| CA | 0.6% | 1.4% |
| BM | 0.7% | 1.2% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)
Check another pair
FAQ
How much do IBB and FBTAX overlap?
What stocks do IBB and FBTAX have in common?
Should I own both IBB and FBTAX?
Which holds more stocks, IBB or FBTAX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.